

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | glyoxylate metabolic process (GO:0046487) | 8.47548854 |
| 2 | complement activation, alternative pathway (GO:0006957) | 8.27759436 |
| 3 | regulation of fibrinolysis (GO:0051917) | 8.23104902 |
| 4 | epoxygenase P450 pathway (GO:0019373) | 8.18361624 |
| 5 | exogenous drug catabolic process (GO:0042738) | 8.05973506 |
| 6 | negative regulation of fibrinolysis (GO:0051918) | 7.73040221 |
| 7 | regulation of protein activation cascade (GO:2000257) | 7.72282508 |
| 8 | omega-hydroxylase P450 pathway (GO:0097267) | 7.66718579 |
| 9 | * drug catabolic process (GO:0042737) | 7.61015985 |
| 10 | urea metabolic process (GO:0019627) | 7.42694249 |
| 11 | peptidyl-glutamic acid carboxylation (GO:0017187) | 7.37499737 |
| 12 | protein carboxylation (GO:0018214) | 7.37499737 |
| 13 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.31965500 |
| 14 | L-phenylalanine catabolic process (GO:0006559) | 7.31965500 |
| 15 | regulation of complement activation (GO:0030449) | 7.25495052 |
| 16 | nitrogen cycle metabolic process (GO:0071941) | 6.74830634 |
| 17 | urea cycle (GO:0000050) | 6.69045342 |
| 18 | L-phenylalanine metabolic process (GO:0006558) | 6.64355005 |
| 19 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 6.64355005 |
| 20 | fibrinolysis (GO:0042730) | 6.52490859 |
| 21 | regulation of triglyceride catabolic process (GO:0010896) | 6.20481559 |
| 22 | ethanol oxidation (GO:0006069) | 6.12211581 |
| 23 | blood coagulation, intrinsic pathway (GO:0007597) | 6.04959672 |
| 24 | serine family amino acid catabolic process (GO:0009071) | 6.02912066 |
| 25 | negative regulation of cholesterol transport (GO:0032375) | 5.92295954 |
| 26 | negative regulation of sterol transport (GO:0032372) | 5.92295954 |
| 27 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.73656263 |
| 28 | bile acid biosynthetic process (GO:0006699) | 5.66835955 |
| 29 | * drug metabolic process (GO:0017144) | 5.60771094 |
| 30 | regulation of plasminogen activation (GO:0010755) | 5.52922259 |
| 31 | cellular glucuronidation (GO:0052695) | 5.34918745 |
| 32 | phospholipid efflux (GO:0033700) | 5.23097361 |
| 33 | protein activation cascade (GO:0072376) | 5.20795387 |
| 34 | bile acid metabolic process (GO:0008206) | 5.15361380 |
| 35 | aromatic amino acid family catabolic process (GO:0009074) | 5.13164649 |
| 36 | glucuronate metabolic process (GO:0019585) | 5.08104351 |
| 37 | uronic acid metabolic process (GO:0006063) | 5.08104351 |
| 38 | ethanol metabolic process (GO:0006067) | 4.98118585 |
| 39 | negative regulation of hemostasis (GO:1900047) | 4.94339376 |
| 40 | negative regulation of blood coagulation (GO:0030195) | 4.94339376 |
| 41 | complement activation (GO:0006956) | 4.91083442 |
| 42 | positive regulation of lipoprotein lipase activity (GO:0051006) | 4.90793281 |
| 43 | positive regulation of triglyceride lipase activity (GO:0061365) | 4.90793281 |
| 44 | glycine metabolic process (GO:0006544) | 4.84241158 |
| 45 | complement activation, classical pathway (GO:0006958) | 4.82507457 |
| 46 | imidazole-containing compound metabolic process (GO:0052803) | 4.80438981 |
| 47 | acute-phase response (GO:0006953) | 4.74672112 |
| 48 | bile acid and bile salt transport (GO:0015721) | 4.74149291 |
| 49 | triglyceride homeostasis (GO:0070328) | 4.72716504 |
| 50 | acylglycerol homeostasis (GO:0055090) | 4.72716504 |
| 51 | regulation of cholesterol esterification (GO:0010872) | 4.69757616 |
| 52 | regulation of humoral immune response (GO:0002920) | 4.67453620 |
| 53 | protein-lipid complex remodeling (GO:0034368) | 4.65994036 |
| 54 | macromolecular complex remodeling (GO:0034367) | 4.65994036 |
| 55 | plasma lipoprotein particle remodeling (GO:0034369) | 4.65994036 |
| 56 | * oxidative demethylation (GO:0070989) | 4.64890364 |
| 57 | high-density lipoprotein particle remodeling (GO:0034375) | 4.50032144 |
| 58 | negative regulation of wound healing (GO:0061045) | 4.46913196 |
| 59 | negative regulation of coagulation (GO:0050819) | 4.46475699 |
| 60 | hormone catabolic process (GO:0042447) | 4.34532239 |
| 61 | arginine metabolic process (GO:0006525) | 4.31614141 |
| 62 | negative regulation of protein activation cascade (GO:2000258) | 4.31564633 |
| 63 | positive regulation of hemostasis (GO:1900048) | 4.31209018 |
| 64 | positive regulation of blood coagulation (GO:0030194) | 4.31209018 |
| 65 | cholesterol efflux (GO:0033344) | 4.31107079 |
| 66 | tyrosine metabolic process (GO:0006570) | 4.20933311 |
| 67 | negative regulation of lipase activity (GO:0060192) | 4.13163767 |
| 68 | opsonization (GO:0008228) | 4.07860194 |
| 69 | S-adenosylmethionine metabolic process (GO:0046500) | 4.04625938 |
| 70 | serine family amino acid metabolic process (GO:0009069) | 3.99810989 |
| 71 | reverse cholesterol transport (GO:0043691) | 3.97091933 |
| 72 | positive regulation of coagulation (GO:0050820) | 3.96377157 |
| 73 | glutamate metabolic process (GO:0006536) | 3.95392144 |
| 74 | regulation of lipoprotein particle clearance (GO:0010984) | 3.94004008 |
| 75 | cytolysis (GO:0019835) | 3.91216830 |
| 76 | alpha-amino acid catabolic process (GO:1901606) | 3.83921710 |
| 77 | amino-acid betaine metabolic process (GO:0006577) | 3.82878443 |
| 78 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.78041413 |
| 79 | acute inflammatory response (GO:0002526) | 3.74368494 |
| 80 | positive regulation of lipid catabolic process (GO:0050996) | 3.74358893 |
| 81 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 3.74063654 |
| 82 | negative regulation of complement activation (GO:0045916) | 3.73982958 |
| 83 | * phenylpropanoid metabolic process (GO:0009698) | 3.67248251 |
| 84 | heme transport (GO:0015886) | 3.65501232 |
| 85 | steroid catabolic process (GO:0006706) | 3.65169535 |
| 86 | flavonoid metabolic process (GO:0009812) | 3.62570760 |
| 87 | sulfur amino acid catabolic process (GO:0000098) | 3.59554377 |
| 88 | plasma lipoprotein particle clearance (GO:0034381) | 3.57048783 |
| 89 | regulation of bile acid biosynthetic process (GO:0070857) | 3.56504108 |
| 90 | serine family amino acid biosynthetic process (GO:0009070) | 3.54974202 |
| 91 | cysteine metabolic process (GO:0006534) | 3.52888565 |
| 92 | proline metabolic process (GO:0006560) | 3.50000342 |
| 93 | plasma lipoprotein particle organization (GO:0071827) | 3.49372854 |
| 94 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 3.44851459 |
| 95 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 3.44851459 |
| 96 | arginine catabolic process (GO:0006527) | 3.42964836 |
| 97 | regulation of apoptotic cell clearance (GO:2000425) | 3.41951043 |
| 98 | cellular ketone body metabolic process (GO:0046950) | 3.41519965 |
| 99 | fat-soluble vitamin biosynthetic process (GO:0042362) | 3.38176299 |
| 100 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.35283654 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 6.79374939 |
| 2 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 6.54258023 |
| 3 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 5.75605963 |
| 4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 5.22546293 |
| 5 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.99349345 |
| 6 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.40778062 |
| 7 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 4.24358447 |
| 8 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.15610684 |
| 9 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.68715680 |
| 10 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.17759018 |
| 11 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 10.3820482 |
| 12 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.95402871 |
| 13 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.94828074 |
| 14 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.87892065 |
| 15 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.84443387 |
| 16 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.78099071 |
| 17 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.69105479 |
| 18 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.53981677 |
| 19 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.40995294 |
| 20 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.32792878 |
| 21 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.31884165 |
| 22 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.30785205 |
| 23 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.24325403 |
| 24 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.22170199 |
| 25 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.21478998 |
| 26 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.13424652 |
| 27 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.12747816 |
| 28 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.12084455 |
| 29 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.08447713 |
| 30 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.02046834 |
| 31 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.02007120 |
| 32 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.98426446 |
| 33 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.97521858 |
| 34 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.96288976 |
| 35 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.94884076 |
| 36 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.94637540 |
| 37 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.93960447 |
| 38 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.93743238 |
| 39 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.93404303 |
| 40 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.92653289 |
| 41 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.91471863 |
| 42 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.91041794 |
| 43 | GATA1_22025678_ChIP-Seq_K562_Human | 0.90529832 |
| 44 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.89578720 |
| 45 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.88946704 |
| 46 | DROSHA_22980978_ChIP-Seq_HELA_Human | 0.88800435 |
| 47 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.87412333 |
| 48 | E2F1_20622854_ChIP-Seq_HELA_Human | 0.86173249 |
| 49 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.85186352 |
| 50 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.83298329 |
| 51 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.82121893 |
| 52 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.81911295 |
| 53 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.80777819 |
| 54 | SA1_27219007_Chip-Seq_Bcells_Human | 0.80307986 |
| 55 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.78365979 |
| 56 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.78086112 |
| 57 | RAC3_21632823_ChIP-Seq_H3396_Human | 0.77704019 |
| 58 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.77678843 |
| 59 | SOX2_21211035_ChIP-Seq_LN229_Human | 0.76181727 |
| 60 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 0.76122998 |
| 61 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.74936868 |
| 62 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.73268062 |
| 63 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.70973479 |
| 64 | CTCF_20526341_ChIP-Seq_ESCs_Human | 0.70601451 |
| 65 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.70013590 |
| 66 | P68_20966046_ChIP-Seq_HELA_Human | 0.69872277 |
| 67 | JARID1B-DAIN_22020125_ChIP-Seq_ESCs_Mouse | 0.69639193 |
| 68 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.69205690 |
| 69 | * EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 0.68730817 |
| 70 | * GATA4_25053715_ChIP-Seq_YYC3_Human | 0.68115462 |
| 71 | PHF8_20622854_ChIP-Seq_HELA_Human | 0.68012849 |
| 72 | P300_27268052_Chip-Seq_Bcells_Human | 0.67987254 |
| 73 | P63_20808887_ChIP-Seq_KERATINOCYTES_Human | 0.66988755 |
| 74 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.66505043 |
| 75 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.65056360 |
| 76 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.64361322 |
| 77 | CDX2_21074721_ChIP-Seq_CACO-2_Mouse | 0.63891873 |
| 78 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.63434418 |
| 79 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.63052892 |
| 80 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.62512654 |
| 81 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.62451427 |
| 82 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.62306523 |
| 83 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.61895502 |
| 84 | ERA_21632823_ChIP-Seq_H3396_Human | 0.61860900 |
| 85 | GATA3_21867929_ChIP-Seq_CD8_Mouse | 0.61599533 |
| 86 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.61536231 |
| 87 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.59425655 |
| 88 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.58273185 |
| 89 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 0.58209312 |
| 90 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.58108000 |
| 91 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 0.57645719 |
| 92 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.56945737 |
| 93 | HNFA_21074721_ChIP-Seq_CACO-2_Human | 0.56037575 |
| 94 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.55993916 |
| 95 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.55664200 |
| 96 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.55634134 |
| 97 | NEUROD2_26341353_ChIP-Seq_CORTEX_Mouse | 0.55524102 |
| 98 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.55042043 |
| 99 | AR_20517297_ChIP-Seq_VCAP_Human | 0.53965466 |
| 100 | MYC_19829295_ChIP-Seq_ESCs_Human | 0.52663409 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 9.24959331 |
| 2 | MP0005360_urolithiasis | 7.40041604 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 6.16065550 |
| 4 | MP0005365_abnormal_bile_salt | 5.72042255 |
| 5 | MP0003195_calcinosis | 5.10466185 |
| 6 | MP0002138_abnormal_hepatobiliary_system | 5.01481972 |
| 7 | MP0008875_abnormal_xenobiotic_pharmacok | 4.93902378 |
| 8 | MP0003252_abnormal_bile_duct | 3.63168955 |
| 9 | MP0003868_abnormal_feces_composition | 3.55675565 |
| 10 | MP0001666_abnormal_nutrient_absorption | 3.31992312 |
| 11 | MP0009697_abnormal_copulation | 2.96138550 |
| 12 | MP0010329_abnormal_lipoprotein_level | 2.77488993 |
| 13 | MP0009840_abnormal_foam_cell | 2.62192271 |
| 14 | MP0003806_abnormal_nucleotide_metabolis | 2.32236052 |
| 15 | MP0005332_abnormal_amino_acid | 2.26015865 |
| 16 | MP0003191_abnormal_cellular_cholesterol | 2.03752857 |
| 17 | MP0002876_abnormal_thyroid_physiology | 2.01175227 |
| 18 | MP0001764_abnormal_homeostasis | 1.86647542 |
| 19 | MP0000609_abnormal_liver_physiology | 1.82286022 |
| 20 | MP0004019_abnormal_vitamin_homeostasis | 1.68714143 |
| 21 | MP0002118_abnormal_lipid_homeostasis | 1.67486746 |
| 22 | MP0010368_abnormal_lymphatic_system | 1.18228749 |
| 23 | MP0005319_abnormal_enzyme/_coenzyme | 1.07920460 |
| 24 | MP0000598_abnormal_liver_morphology | 1.02859929 |
| 25 | MP0005451_abnormal_body_composition | 1.00991036 |
| 26 | MP0009643_abnormal_urine_homeostasis | 0.99586687 |
| 27 | MP0000604_amyloidosis | 0.98325243 |
| 28 | MP0002132_abnormal_respiratory_system | 0.98030245 |
| 29 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.93917733 |
| 30 | MP0002971_abnormal_brown_adipose | 0.93789279 |
| 31 | MP0009053_abnormal_anal_canal | 0.86793686 |
| 32 | MP0005670_abnormal_white_adipose | 0.86459133 |
| 33 | MP0008469_abnormal_protein_level | 0.85233468 |
| 34 | MP0005376_homeostasis/metabolism_phenot | 0.84727947 |
| 35 | MP0005408_hypopigmentation | 0.84363553 |
| 36 | MP0009642_abnormal_blood_homeostasis | 0.84118649 |
| 37 | MP0003879_abnormal_hair_cell | 0.83788507 |
| 38 | MP0009764_decreased_sensitivity_to | 0.83592938 |
| 39 | MP0001661_extended_life_span | 0.81668697 |
| 40 | MP0001915_intracranial_hemorrhage | 0.79782087 |
| 41 | MP0009763_increased_sensitivity_to | 0.79766101 |
| 42 | MP0002249_abnormal_larynx_morphology | 0.74895644 |
| 43 | MP0003690_abnormal_glial_cell | 0.71238805 |
| 44 | MP0003656_abnormal_erythrocyte_physiolo | 0.70868709 |
| 45 | MP0005535_abnormal_body_temperature | 0.69419602 |
| 46 | MP0005058_abnormal_lysosome_morphology | 0.68697467 |
| 47 | MP0005636_abnormal_mineral_homeostasis | 0.67391449 |
| 48 | MP0002168_other_aberrant_phenotype | 0.66104238 |
| 49 | MP0005395_other_phenotype | 0.65843012 |
| 50 | MP0009785_altered_susceptibility_to | 0.64312992 |
| 51 | MP0005464_abnormal_platelet_physiology | 0.61532423 |
| 52 | MP0005187_abnormal_penis_morphology | 0.61216627 |
| 53 | MP0008874_decreased_physiological_sensi | 0.60700635 |
| 54 | MP0003186_abnormal_redox_activity | 0.58155411 |
| 55 | MP0005334_abnormal_fat_pad | 0.57875274 |
| 56 | MP0003436_decreased_susceptibility_to | 0.57143815 |
| 57 | MP0002078_abnormal_glucose_homeostasis | 0.56459482 |
| 58 | MP0003638_abnormal_response/metabolism_ | 0.55373306 |
| 59 | MP0000249_abnormal_blood_vessel | 0.53023183 |
| 60 | MP0002282_abnormal_trachea_morphology | 0.51791566 |
| 61 | MP0005166_decreased_susceptibility_to | 0.51330394 |
| 62 | MP0001986_abnormal_taste_sensitivity | 0.50046223 |
| 63 | MP0003705_abnormal_hypodermis_morpholog | 0.49053900 |
| 64 | MP0008872_abnormal_physiological_respon | 0.48964590 |
| 65 | MP0005266_abnormal_metabolism | 0.48374032 |
| 66 | MP0005448_abnormal_energy_balance | 0.42942246 |
| 67 | MP0004883_abnormal_blood_vessel | 0.40959113 |
| 68 | MP0002136_abnormal_kidney_physiology | 0.40451176 |
| 69 | MP0003075_altered_response_to | 0.40421317 |
| 70 | MP0009115_abnormal_fat_cell | 0.40227062 |
| 71 | MP0001845_abnormal_inflammatory_respons | 0.39429540 |
| 72 | MP0000566_synostosis | 0.39257180 |
| 73 | MP0005164_abnormal_response_to | 0.38991590 |
| 74 | MP0010155_abnormal_intestine_physiology | 0.38488637 |
| 75 | MP0003011_delayed_dark_adaptation | 0.37320276 |
| 76 | MP0010386_abnormal_urinary_bladder | 0.36468157 |
| 77 | MP0005023_abnormal_wound_healing | 0.36248995 |
| 78 | MP0004130_abnormal_muscle_cell | 0.34608393 |
| 79 | MP0003183_abnormal_peptide_metabolism | 0.34250998 |
| 80 | MP0005025_abnormal_response_to | 0.33936948 |
| 81 | MP0002822_catalepsy | 0.32173306 |
| 82 | MP0009765_abnormal_xenobiotic_induced | 0.31473634 |
| 83 | MP0002970_abnormal_white_adipose | 0.30800352 |
| 84 | MP0005083_abnormal_biliary_tract | 0.30204817 |
| 85 | MP0002928_abnormal_bile_duct | 0.29445517 |
| 86 | MP0002419_abnormal_innate_immunity | 0.29071371 |
| 87 | MP0005409_darkened_coat_color | 0.28133036 |
| 88 | MP0003953_abnormal_hormone_level | 0.27783469 |
| 89 | MP0003959_abnormal_lean_body | 0.27363108 |
| 90 | MP0000467_abnormal_esophagus_morphology | 0.26133296 |
| 91 | MP0000685_abnormal_immune_system | 0.25368543 |
| 92 | MP0004782_abnormal_surfactant_physiolog | 0.25245895 |
| 93 | MP0006036_abnormal_mitochondrial_physio | 0.24360585 |
| 94 | MP0002089_abnormal_postnatal_growth/wei | 0.21630147 |
| 95 | MP0001545_abnormal_hematopoietic_system | 0.21350784 |
| 96 | MP0005397_hematopoietic_system_phenotyp | 0.21350784 |
| 97 | MP0003329_amyloid_beta_deposits | 0.21211589 |
| 98 | MP0000003_abnormal_adipose_tissue | 0.21154300 |
| 99 | MP0005220_abnormal_exocrine_pancreas | 0.20973106 |
| 100 | MP0001851_eye_inflammation | 0.19145026 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Prolonged partial thromboplastin time (HP:0003645) | 9.16164832 |
| 2 | Complement deficiency (HP:0004431) | 8.89478194 |
| 3 | Hypobetalipoproteinemia (HP:0003563) | 7.62064811 |
| 4 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 7.48282705 |
| 5 | Abnormality of complement system (HP:0005339) | 7.18811580 |
| 6 | Joint hemorrhage (HP:0005261) | 6.85798620 |
| 7 | Systemic lupus erythematosus (HP:0002725) | 6.65425891 |
| 8 | Hyperlipoproteinemia (HP:0010980) | 5.75397130 |
| 9 | Abnormality of pyrimidine metabolism (HP:0004353) | 5.58197507 |
| 10 | Conjugated hyperbilirubinemia (HP:0002908) | 5.40538349 |
| 11 | Glomerulonephritis (HP:0000099) | 5.15505565 |
| 12 | Xanthomatosis (HP:0000991) | 5.14311116 |
| 13 | Intrahepatic cholestasis (HP:0001406) | 4.89724271 |
| 14 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.43235085 |
| 15 | Hypolipoproteinemia (HP:0010981) | 4.37265738 |
| 16 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.28517701 |
| 17 | Abnormality of the common coagulation pathway (HP:0010990) | 4.14811620 |
| 18 | Abnormality of the intrinsic pathway (HP:0010989) | 3.75645615 |
| 19 | Nephritis (HP:0000123) | 3.71571745 |
| 20 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.69527977 |
| 21 | Spontaneous abortion (HP:0005268) | 3.67349091 |
| 22 | Hemorrhage of the eye (HP:0011885) | 3.38997770 |
| 23 | Hypoalphalipoproteinemia (HP:0003233) | 3.33370839 |
| 24 | Hyperammonemia (HP:0001987) | 3.20676562 |
| 25 | Delayed CNS myelination (HP:0002188) | 3.07279067 |
| 26 | Fat malabsorption (HP:0002630) | 3.02709818 |
| 27 | Gingival bleeding (HP:0000225) | 2.98790996 |
| 28 | Abnormality of nucleobase metabolism (HP:0010932) | 2.95300803 |
| 29 | Menorrhagia (HP:0000132) | 2.94785965 |
| 30 | Hyperglycinemia (HP:0002154) | 2.94615404 |
| 31 | Abnormality of glycine metabolism (HP:0010895) | 2.79751860 |
| 32 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.79751860 |
| 33 | Generalized aminoaciduria (HP:0002909) | 2.78977200 |
| 34 | Purpura (HP:0000979) | 2.72870248 |
| 35 | Pulmonary embolism (HP:0002204) | 2.71001616 |
| 36 | Abnormality of methionine metabolism (HP:0010901) | 2.68969329 |
| 37 | Hypercholesterolemia (HP:0003124) | 2.62358632 |
| 38 | Abnormal gallbladder physiology (HP:0012438) | 2.57762166 |
| 39 | Cholecystitis (HP:0001082) | 2.57762166 |
| 40 | Mitral stenosis (HP:0001718) | 2.53462194 |
| 41 | Osteomalacia (HP:0002749) | 2.52416840 |
| 42 | Thrombophlebitis (HP:0004418) | 2.52313341 |
| 43 | Neonatal hypoglycemia (HP:0001998) | 2.51449884 |
| 44 | Reduced antithrombin III activity (HP:0001976) | 2.49452181 |
| 45 | Rickets (HP:0002748) | 2.45924863 |
| 46 | Vascular calcification (HP:0004934) | 2.45488149 |
| 47 | Abnormality of serum amino acid levels (HP:0003112) | 2.45083623 |
| 48 | Epidermoid cyst (HP:0200040) | 2.45047553 |
| 49 | Hyperglycinuria (HP:0003108) | 2.41823545 |
| 50 | Fair hair (HP:0002286) | 2.41698740 |
| 51 | Hepatocellular carcinoma (HP:0001402) | 2.39254633 |
| 52 | Steatorrhea (HP:0002570) | 2.32488440 |
| 53 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.28937295 |
| 54 | Hyperbilirubinemia (HP:0002904) | 2.28093636 |
| 55 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.19434495 |
| 56 | Elevated alkaline phosphatase (HP:0003155) | 2.18919498 |
| 57 | Metabolic acidosis (HP:0001942) | 2.17044278 |
| 58 | Increased serum ferritin (HP:0003281) | 2.16118943 |
| 59 | Cardiovascular calcification (HP:0011915) | 2.13937038 |
| 60 | Abnormality of the Achilles tendon (HP:0005109) | 2.13214980 |
| 61 | Gangrene (HP:0100758) | 2.09322275 |
| 62 | Cholelithiasis (HP:0001081) | 2.09237303 |
| 63 | Abnormal enzyme/coenzyme activity (HP:0012379) | 2.05386073 |
| 64 | Abnormality of alkaline phosphatase activity (HP:0004379) | 2.02561743 |
| 65 | Abnormality of iron homeostasis (HP:0011031) | 2.01135335 |
| 66 | Hydroxyprolinuria (HP:0003080) | 2.00934385 |
| 67 | Abnormality of proline metabolism (HP:0010907) | 2.00934385 |
| 68 | Myocardial infarction (HP:0001658) | 2.00041730 |
| 69 | Deep venous thrombosis (HP:0002625) | 10.6391028 |
| 70 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 10.2927982 |
| 71 | Arthropathy (HP:0003040) | 1.96073110 |
| 72 | Atrioventricular block (HP:0001678) | 1.94626814 |
| 73 | Irritability (HP:0000737) | 1.93217798 |
| 74 | Abnormal gallbladder morphology (HP:0012437) | 1.92390205 |
| 75 | Epistaxis (HP:0000421) | 1.88601454 |
| 76 | Hyperphosphaturia (HP:0003109) | 1.87369583 |
| 77 | Hypophosphatemic rickets (HP:0004912) | 1.80218038 |
| 78 | Alkalosis (HP:0001948) | 1.78520387 |
| 79 | Ketosis (HP:0001946) | 1.77186610 |
| 80 | Glycosuria (HP:0003076) | 1.76568658 |
| 81 | Abnormality of urine glucose concentration (HP:0011016) | 1.76568658 |
| 82 | Hypochromic microcytic anemia (HP:0004840) | 1.76412969 |
| 83 | Hypophosphatemia (HP:0002148) | 1.75208111 |
| 84 | Abnormality of vitamin metabolism (HP:0100508) | 1.75108521 |
| 85 | Abnormality of purine metabolism (HP:0004352) | 1.74806480 |
| 86 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.73762117 |
| 87 | Generalized hypopigmentation of hair (HP:0011358) | 1.69711724 |
| 88 | Pancreatitis (HP:0001733) | 1.68088646 |
| 89 | Joint swelling (HP:0001386) | 1.67146717 |
| 90 | Abnormal urine phosphate concentration (HP:0012599) | 1.66215926 |
| 91 | Abnormal biliary tract physiology (HP:0012439) | 1.59996963 |
| 92 | Bile duct proliferation (HP:0001408) | 1.59996963 |
| 93 | Cerebral palsy (HP:0100021) | 1.59403725 |
| 94 | Enlarged kidneys (HP:0000105) | 1.55886899 |
| 95 | Gout (HP:0001997) | 1.54277141 |
| 96 | Poikilocytosis (HP:0004447) | 1.53205791 |
| 97 | Blue irides (HP:0000635) | 1.53176612 |
| 98 | Bifid scrotum (HP:0000048) | 1.52563256 |
| 99 | Skin nodule (HP:0200036) | 1.50459834 |
| 100 | Malnutrition (HP:0004395) | 1.49167393 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ERN1 | 5.91412943 |
| 2 | FGFR4 | 4.30651421 |
| 3 | TRIB3 | 4.11033967 |
| 4 | RIPK1 | 3.12980546 |
| 5 | PRPF4B | 2.96787586 |
| 6 | SIK1 | 2.92434792 |
| 7 | PIK3CG | 2.61667936 |
| 8 | TYK2 | 2.36080226 |
| 9 | MST1R | 1.98952358 |
| 10 | MAP4K1 | 1.81274507 |
| 11 | TNK2 | 1.80685409 |
| 12 | FGFR3 | 1.77634824 |
| 13 | TBK1 | 1.77065849 |
| 14 | PRKACG | 1.54472866 |
| 15 | MAP3K3 | 1.48695146 |
| 16 | MAPK11 | 1.47694030 |
| 17 | BCKDK | 1.37610414 |
| 18 | BLK | 1.34013942 |
| 19 | EPHB1 | 1.31552424 |
| 20 | PIK3CA | 1.30331275 |
| 21 | PKN2 | 1.27991822 |
| 22 | MAP2K4 | 1.27148952 |
| 23 | TAOK3 | 1.26484074 |
| 24 | EPHA3 | 1.25343367 |
| 25 | PDPK1 | 1.23239999 |
| 26 | PRKAA2 | 1.21154268 |
| 27 | JAK1 | 1.19712727 |
| 28 | NTRK3 | 1.18960977 |
| 29 | MAP3K6 | 1.14124868 |
| 30 | ZAP70 | 1.13152878 |
| 31 | GRK6 | 1.10526949 |
| 32 | MAPK7 | 1.08072999 |
| 33 | MAPK15 | 1.07689817 |
| 34 | MAP2K3 | 1.06490640 |
| 35 | SIK2 | 1.04592292 |
| 36 | CDK12 | 1.04282876 |
| 37 | CAMKK1 | 1.01778558 |
| 38 | IKBKE | 0.99954197 |
| 39 | ERBB2 | 0.98017583 |
| 40 | ICK | 0.97902203 |
| 41 | MAPK12 | 0.96742110 |
| 42 | PRKCG | 0.92031207 |
| 43 | CDC42BPA | 0.91721003 |
| 44 | CSF1R | 0.90885699 |
| 45 | MAP3K11 | 0.90559073 |
| 46 | NLK | 0.90541218 |
| 47 | PDK1 | 0.89009702 |
| 48 | MAP3K1 | 0.85777500 |
| 49 | PTK6 | 0.84704457 |
| 50 | MAP3K7 | 0.82666977 |
| 51 | MARK2 | 0.79264283 |
| 52 | PRKCZ | 0.78887243 |
| 53 | RET | 0.78880303 |
| 54 | DYRK1B | 0.78545854 |
| 55 | MAP3K14 | 0.72044814 |
| 56 | CDK4 | 0.69008581 |
| 57 | JAK2 | 0.68601927 |
| 58 | TAOK2 | 0.68487012 |
| 59 | MAP2K2 | 0.67228916 |
| 60 | IGF1R | 0.63570905 |
| 61 | PRKAA1 | 0.61802451 |
| 62 | ACVR1B | 0.61716098 |
| 63 | CDK6 | 0.61501531 |
| 64 | ABL2 | 0.61386781 |
| 65 | CHUK | 0.58954383 |
| 66 | TAOK1 | 0.58896556 |
| 67 | MTOR | 0.58866478 |
| 68 | MET | 0.57428720 |
| 69 | FES | 0.57185086 |
| 70 | PRKACA | 0.56838179 |
| 71 | IRAK3 | 0.55682712 |
| 72 | PRKG1 | 0.55585025 |
| 73 | MAPK4 | 0.54601895 |
| 74 | SMG1 | 0.54377578 |
| 75 | MAP3K13 | 0.54369949 |
| 76 | SGK1 | 0.53843748 |
| 77 | FGFR2 | 0.51958840 |
| 78 | MAP2K6 | 0.51881252 |
| 79 | MUSK | 0.49592931 |
| 80 | STK38 | 0.49229482 |
| 81 | CAMK1D | 0.48356358 |
| 82 | MAP3K2 | 0.48211618 |
| 83 | MAPK3 | 0.46555628 |
| 84 | SGK223 | 0.46279905 |
| 85 | SGK494 | 0.46279905 |
| 86 | KIT | 0.46194821 |
| 87 | IRAK1 | 0.44464912 |
| 88 | JAK3 | 0.44064334 |
| 89 | NEK9 | 0.43893987 |
| 90 | CSNK1D | 0.43126670 |
| 91 | RPS6KA3 | 0.42835360 |
| 92 | KDR | 0.41965256 |
| 93 | PRKCA | 0.41799827 |
| 94 | IKBKB | 0.40971827 |
| 95 | PRKD2 | 0.40159275 |
| 96 | LCK | 0.39918406 |
| 97 | AKT3 | 0.38701963 |
| 98 | PRKCB | 0.37422874 |
| 99 | INSRR | 0.36974958 |
| 100 | SRC | 0.36869743 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 4.25579495 |
| 2 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.10887009 |
| 3 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 4.01553478 |
| 4 | Caffeine metabolism_Homo sapiens_hsa00232 | 3.48841907 |
| 5 | Retinol metabolism_Homo sapiens_hsa00830 | 3.30216009 |
| 6 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.20631033 |
| 7 | * Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 3.20304400 |
| 8 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 3.05151504 |
| 9 | Arginine biosynthesis_Homo sapiens_hsa00220 | 3.01024126 |
| 10 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 2.82134511 |
| 11 | * Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 2.68272218 |
| 12 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 2.61083032 |
| 13 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 2.55525468 |
| 14 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.54349516 |
| 15 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 2.39512164 |
| 16 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.37144266 |
| 17 | Tyrosine metabolism_Homo sapiens_hsa00350 | 2.20048827 |
| 18 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.19581636 |
| 19 | Histidine metabolism_Homo sapiens_hsa00340 | 2.13867360 |
| 20 | Bile secretion_Homo sapiens_hsa04976 | 2.04498437 |
| 21 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.86960832 |
| 22 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.70344534 |
| 23 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.67837133 |
| 24 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.62274366 |
| 25 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.54926853 |
| 26 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.53687883 |
| 27 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.49791554 |
| 28 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.49673957 |
| 29 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.47779999 |
| 30 | Peroxisome_Homo sapiens_hsa04146 | 1.35076868 |
| 31 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.28049114 |
| 32 | Prion diseases_Homo sapiens_hsa05020 | 1.27081911 |
| 33 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.26329023 |
| 34 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.26294813 |
| 35 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.25748015 |
| 36 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.23036339 |
| 37 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.15584935 |
| 38 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.13729855 |
| 39 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.09176252 |
| 40 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.07477351 |
| 41 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.07180078 |
| 42 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.05114501 |
| 43 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.03349806 |
| 44 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.01061732 |
| 45 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.95146812 |
| 46 | Sulfur relay system_Homo sapiens_hsa04122 | 0.85817333 |
| 47 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.85539873 |
| 48 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.83735901 |
| 49 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.83566012 |
| 50 | Carbon metabolism_Homo sapiens_hsa01200 | 0.82533460 |
| 51 | ABC transporters_Homo sapiens_hsa02010 | 0.78737287 |
| 52 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.72487041 |
| 53 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.64619743 |
| 54 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.64146803 |
| 55 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.59783892 |
| 56 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.59551448 |
| 57 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.57312371 |
| 58 | Lysine degradation_Homo sapiens_hsa00310 | 0.55136470 |
| 59 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.50698858 |
| 60 | Pertussis_Homo sapiens_hsa05133 | 0.44095421 |
| 61 | Metabolic pathways_Homo sapiens_hsa01100 | 0.38561924 |
| 62 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.38242841 |
| 63 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.37679689 |
| 64 | Insulin resistance_Homo sapiens_hsa04931 | 0.36306701 |
| 65 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.33703141 |
| 66 | Other glycan degradation_Homo sapiens_hsa00511 | 0.29897616 |
| 67 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.27557145 |
| 68 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.24324535 |
| 69 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.23653238 |
| 70 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.21345447 |
| 71 | Galactose metabolism_Homo sapiens_hsa00052 | 0.18030078 |
| 72 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.17872111 |
| 73 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.17116399 |
| 74 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.16100948 |
| 75 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.15944224 |
| 76 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.11287939 |
| 77 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.05426055 |
| 78 | Amoebiasis_Homo sapiens_hsa05146 | 0.05308603 |
| 79 | Mineral absorption_Homo sapiens_hsa04978 | 0.03230573 |
| 80 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | -0.2339220 |
| 81 | Protein digestion and absorption_Homo sapiens_hsa04974 | -0.2135640 |
| 82 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | -0.2098945 |
| 83 | Circadian rhythm_Homo sapiens_hsa04710 | -0.2046447 |
| 84 | Ether lipid metabolism_Homo sapiens_hsa00565 | -0.2031535 |
| 85 | Selenocompound metabolism_Homo sapiens_hsa00450 | -0.1986749 |
| 86 | Hepatitis C_Homo sapiens_hsa05160 | -0.1972500 |
| 87 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.1582200 |
| 88 | Type II diabetes mellitus_Homo sapiens_hsa04930 | -0.1315577 |
| 89 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | -0.1248582 |
| 90 | Sphingolipid metabolism_Homo sapiens_hsa00600 | -0.1173910 |
| 91 | * Serotonergic synapse_Homo sapiens_hsa04726 | -0.1149854 |
| 92 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.1146576 |
| 93 | Folate biosynthesis_Homo sapiens_hsa00790 | -0.1071849 |
| 94 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | -0.1054308 |
| 95 | Steroid biosynthesis_Homo sapiens_hsa00100 | -0.1028778 |
| 96 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | -0.1028697 |
| 97 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.0957344 |
| 98 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.0429492 |
| 99 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | -0.0163503 |
| 100 | Glutathione metabolism_Homo sapiens_hsa00480 | -0.0026027 |

